Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,981 | 5 | 49.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,670 | 6 | 37.1% |
| Food and Beverage | $2,406 | 120 | 7.1% |
| Travel and Lodging | $2,050 | 4 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $31,369 | 22 | $0 (2019) |
| Gilead Sciences, Inc. | $616.36 | 31 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $493.48 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $245.39 | 12 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $211.10 | 13 | $0 (2021) |
| Dr.Reddy's Laboratories,Inc. | $190.00 | 1 | $0 (2017) |
| Sentynl Therapeutics, Inc. | $160.00 | 1 | $0 (2018) |
| Synergy Pharmaceuticals Inc | $121.92 | 1 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $110.76 | 6 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $100.93 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $232.48 | 11 | Janssen Biotech, Inc. ($122.92) |
| 2023 | $252.50 | 13 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($90.76) |
| 2022 | $127.03 | 7 | Gilead Sciences, Inc. ($61.39) |
| 2021 | $343.88 | 14 | Gilead Sciences, Inc. ($160.15) |
| 2020 | $203.17 | 10 | Gilead Sciences, Inc. ($73.69) |
| 2019 | $313.01 | 21 | Gilead Sciences, Inc. ($96.59) |
| 2018 | $5,446 | 23 | Covidien LP ($4,995) |
| 2017 | $27,189 | 36 | Covidien LP ($26,334) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.55 | General |
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.17 | General |
| 09/04/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.37 | General |
| 06/28/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: Immunology | ||||||
| 06/05/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: Immunology | ||||||
| 05/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.03 | General |
| 03/06/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Immunology | ||||||
| 02/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.21 | General |
| 12/20/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.62 | General |
| 11/28/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Immunology | ||||||
| 09/07/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.87 | General |
| 06/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.40 | General |
| 06/21/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: GI COLON PREP | ||||||
| 06/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Gastroenterology | ||||||
| 06/07/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: GI COLON PREP | ||||||
| 05/31/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.45 | General |
| 05/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Gastroenterology | ||||||
| 05/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Gastroenterology | ||||||
| 05/03/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Immunology | ||||||
| 05/03/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Gastroenterology | ||||||
| 03/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Gastroenterology | ||||||
| 11/02/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 338 | 370 | $252,376 | $64,457 |
| 2022 | 11 | 315 | 352 | $231,698 | $61,433 |
| 2021 | 11 | 390 | 417 | $223,732 | $65,564 |
| 2020 | 11 | 294 | 312 | $166,306 | $43,124 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 110 | $39,490 | $12,012 | 30.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 26 | 26 | $34,200 | $11,912 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $28,177 | $7,979 | 28.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 26 | 26 | $28,632 | $7,524 | 26.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 44 | $21,146 | $6,963 | 32.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 32 | 32 | $40,444 | $6,121 | 15.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2023 | 16 | 16 | $15,815 | $5,321 | 33.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 11 | 11 | $14,469 | $2,769 | 19.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 14 | $4,618 | $1,521 | 32.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $20,923 | $1,293 | 6.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $4,460 | $1,044 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 116 | $43,868 | $13,555 | 30.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 29 | 29 | $34,623 | $8,456 | 24.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 16 | 16 | $22,655 | $7,504 | 33.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2022 | 17 | 17 | $18,073 | $6,609 | 36.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 24 | 24 | $32,953 | $6,277 | 19.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $21,751 | $6,093 | 28.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 12 | 12 | $12,736 | $3,243 | 25.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $8,023 | $2,651 | 33.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $8,292 | $2,449 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 22 | $4,425 | $1,572 | 35.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 16 | 17 | $19,871 | $1,564 | 7.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 15 | $4,427 | $1,459 | 33.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 102 | $38,501 | $12,188 | 31.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 52 | 52 | $29,801 | $9,845 | 33.0% |
About Dr. Deepak Vadada, MD
Dr. Deepak Vadada, MD is a Gastroenterology healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2009. The National Provider Identifier (NPI) number assigned to this provider is 1003042672.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepak Vadada, MD has received a total of $34,107 in payments from pharmaceutical and medical device companies, with $232.48 received in 2024. These payments were reported across 135 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($16,981).
As a Medicare-enrolled provider, Vadada has provided services to 1,337 Medicare beneficiaries, totaling 1,451 services with total Medicare billing of $234,579. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Staten Island, NY
- Active Since 06/09/2009
- Last Updated 10/13/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1003042672
Products in Payments
- HET (Device) $15,480
- Barrx (Device) $3,045
- PillCam (Device) $2,393
- Entyvio (Biological) $452.89
- STELARA (Biological) $205.41
- Trulance (Drug) $121.92
- ZEPATIER (Drug) $117.66
- GIVLAARI (Drug) $96.83
- Beacon (Device) $72.97
- ZEPOSIA (Drug) $67.08
- GENERAL - BILIARY DEVICES (Device) $59.76
- TRULANCE (Drug) $58.28
- LINZESS (Drug) $55.73
- XIFAXAN (Drug) $52.48
- DIFICID (Drug) $41.08
- VIBERZI (Drug) $37.30
- SUTAB (Drug) $32.57
- Cook Medical AcuSnare (Device) $28.11
- Linzess (Drug) $26.46
- Cook Medical Endoscopic Ultrasound (Device) $25.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Staten Island
Dr. Sherif Farag, Md, MD
Gastroenterology — Payments: $160,829
Dr. Sherif Andrawes, Md, MD
Gastroenterology — Payments: $92,017
Daniel Megna, Md, MD
Gastroenterology — Payments: $14,432
Anu Sampat, Md, MD
Gastroenterology — Payments: $12,199
Richard Fazio, M.d, M.D
Gastroenterology — Payments: $11,738
Mr. Lawrence Mancino, Do, DO
Gastroenterology — Payments: $10,841